DEBILOCK 110 CAPSULE

Product Description

DEBILOCK 110 CAPSULE is a high-efficacy oral anticoagulant containing Dabigatran Etexilate 110 mg, designed to prevent and reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It offers a modern, convenient alternative to traditional anticoagulants, with predictable pharmacokinetics that eliminate the need for routine monitoring.

Manufactured under strict WHO-GMP and FDA-approved standards, DEBILOCK 110 is trusted by cardiologists and healthcare providers for safe, reliable blood thinning.

Key Benefits:

• Effective prevention of stroke and systemic embolism

• Suitable for patients with non-valvular atrial fibrillation

• Predictable anticoagulant effect with fixed dosing

• Reduced risk of major bleeding events compared to conventional therapy

Applications:

• Prevention of stroke in atrial fibrillation patients

• Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Recommended in cardiology and vascular medicine protocols

Ideal For:

• Pharmaceutical distributors, hospital pharmacies, and bulk medicine buyers

• Medical wholesalers catering to cardiovascular care markets

• Government tenders and institutional supply chains